Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 Articles
14 Articles
Helena Independent Record
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Aug. 20, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the "Company") today announced it awarded inducement grants on August 20, 2026 under the Company's 2026 Employment Inducement Incentive Award Plan (the "2026 Inducement Plan") as a material…
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PressReach
SAN DIEGO, Aug. 20, 2026 /PRNewswire/ — Atrium Therapeutics, Inc. (Nasdaq: RNA) (the “Company”) today announced it awarded inducement grants on August 20, 2026 under the Company’s 2026 Employment Inducement Incentive Award Plan (the “2026 Inducement Plan”) as a material inducement to the employment of one non-executive individual newly hired by the Company. The employee received, in the aggregate, non-qualified stock options to purchase 11,000 …
Coverage Details
Bias Distribution
- 84% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
